[1]Karras DJ,Kruus LK,Cienki JJ,et al.Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments:a multicenter study[J].Ann Emerg Med,2006,47(3):230-236.
[2]Martin JF,Higashiama E,Garcia E,et al.Hypertensive crisis profile.Prevalence and clinical presentation[J].Arq Bras Cardiol,2004,83(2):131-136,125-130.
[3]Derhaschnig U,Testori C,Riedmueller E,et al.Hypertensive emergencies are associated with elevated markers of inflammation,coagulation,platelet activation and fibrinolysis[J].J Hum Hypertens,2013,27(6):368-373.
[4]Kessler CS,Joudeh Y.Evaluation and treatment of severe asymptomatic hypertension[J].Am Fam Physician,2010,81(4):470-476.
[5]Kuppasani K,Reddi AS.Emergency or urgency? Effective management of hypertensive crises[J].JAAPA,2010,23(8):44-49.
[6]Padilla Ramos A,Varon J.Current and newer agents for hypertensive emergencies[J].Curr Hypertens Rep,2014,16(7):450.
[7]Johnson W,Nguyen ML,Patel R.Hypertension crisis in the emergency department[J].Cardiol Clin,2012,30(4):533-543.
[8]van den Born BJ,Beutler JJ,Gaillard CA,et al.Dutch guideline for the management of hypertensive crisis-2010 revision[J].Neth J Med,2011,69(5):248-255.
[9]Papadopoulos DP,Mourouzis I,Thomopoulos C,et al.Hypertension crisis[J].Blood Press,2010,19(6):328-336.
[10]Cohn JN,McInnes GT,Shepherd AM.Direct-acting vasodilators[J].J Clin Hypertens(Greenwich),2011,13(9):690-692.
[11]Wong MF,Yen ZS.Towards evidence based emergency medicine:best BETs from the Manchester Royal Infirmary.BET 1.Nicardipine hydrochloride for hypertensive crisis in patients with aortic dissection[J].Emerg Med J,2011,28(1):74-75.
[12]Minushkina LO.Features of urapidil in treatment of resistant hypertension[J].Kardiologiia,2012,52(8):77-82.
[13]Tobe SW:beta-adrenergic receptor blockers in hypertension[J].Can J Cardiol,2014,30(5 Suppl):S1-2. |